Novel Applications of Combination Therapy for Infection Prevention and Control

This inventive concept leverages the core technology of the original patent to develop novel applications for preventing and controlling infections in various industries, including food safety, agriculture, medical devices, environmental pollution, and metal corrosion.

The original patent focused on treating and preventing infections in humans using a combination of antibiotic and vaccine therapy. However, this approach can be limited in its application to other fields. The new inventive concept addresses this limitation by exploring the use of combination therapy in entirely different industries, such as food safety, agriculture, and environmental pollution, where microbial growth and infection pose significant challenges.

The inventive concept involves the administration of a combination of antimicrobial agents and vaccines directed to specific causative agents of infection in various industries. For instance, in food safety, the combination therapy can be used to prevent microbial growth and spoilage in food products or packaging materials. In agriculture, the combination therapy can be used to reduce the risk of crop failure due to disease by administering a pesticide and vaccine to crops. Similarly, in medical devices, the combination therapy can be used to prevent biofilm formation on medical implants by applying a coating comprising antimicrobial agents and a vaccine. In environmental pollution, the combination therapy can be used to reduce the risk of oil spills by administering a bioremediation agent and vaccine to oil spill sites. Finally, in metal corrosion, the combination therapy can be used to prevent corrosion of metal surfaces by applying a coating comprising corrosion inhibitors and a vaccine.

The new inventive concept introduces a novel application of combination therapy beyond human infections, providing a non-obvious solution to the problem of microbial growth and infection in various industries. The inventive step lies in the recognition of the potential for combination therapy to be applied to different fields and the development of specific formulations and administration protocols tailored to each industry.

Alternative embodiments of the inventive concept could include the use of different types of antimicrobial agents, vaccines, and administration protocols tailored to specific industries. Additionally, the combination therapy could be used in conjunction with other technologies, such as nanotechnology or biotechnology, to enhance its effectiveness.

The inventive concept has significant commercial potential in various industries, including food safety, agriculture, medical devices, environmental pollution, and metal corrosion. The market for combination therapy in these industries is substantial, with potential applications in food processing, agricultural production, medical device manufacturing, environmental remediation, and metal surface treatment.